Renew Health introduces virtual outpatient rehab in New Mexico, providing expert alcohol withdrawal treatment and ...

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...

In a placebo-controlled randomized trial, adults with obesity and alcohol use disorder had a greater drop in heavy drinking ...

Alcohol withdrawal is associated with positive changes in the composition and function of the gut microbiome, improving our understanding of the gut's influence on physiological and behavioral health, ...

Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...

Research indicates semaglutide can significantly decrease alcohol consumption and cravings in individuals with comorbid ...

Please provide your email address to receive an email when new articles are posted on . Postdischarge pharmacotherapy rates rose from 12.6% in 2014 to 23.9% in 2023 for ALD-related hospitalizations.

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

PHILADELPHIA — Patients with alcohol-associated liver disease (ALD) could benefit from treatment of alcohol use disorder (AUD), yet pharmacologic therapy remains underutilized in this at-risk group, ...

Life is hard enough. Getting help should not be stressful. You can get all of your mental health and substance use disorders treatment in one place--and we will collaborate with each other to get you ...